CymaBay Therapeutics Inc. (CBAY)
NASDAQ: CBAY
· Real-Time Price · USD
32.48
0.01 (0.03%)
At close: Mar 21, 2024, 9:00 PM
CymaBay Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -15.97 | -11.63 | -346.09 | -6.09 | -3.78 | -2.68 | -2.05 | -2.17 | -2.2 | -2.78 | -3.24 | -4.46 |
PEG Ratio | -1.02 | -0.00 | 3.54 | 0.50 | -0.16 | 0.32 | n/a | 0.41 | -0.15 | 0.94 | -0.09 | -0.51 |
PS Ratio | 46.96K | n/a | 36.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 9.16 | 4.83 | 10.32 | 8.20 | 15.23 | 4.93 | 3.03 | 2.51 | 1.75 | 2.89 | 2.81 | 2.45 |
P/FCF Ratio | -97.12 | -60.29 | -43.85 | 137.00 | -29.33 | -16.9 | -11.07 | -10.64 | -16.39 | -16.35 | -15.66 | -15.15 |
P/OCF Ratio | -97.76 | -60.29 | -43.97 | 132.84 | -29.35 | -16.91 | -11.13 | -10.64 | -16.38 | -16.35 | -15.65 | -15.22 |
OCF/S Ratio | -480.35 | n/a | -0.82 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.39 | 0.32 | 0.92 | 0.91 | 2.51 | 1.45 | 1.01 | 0.74 | 0.39 | 0.28 | 0.01 | 0.01 |
Quick Ratio | 10.96 | 22.76 | 12.52 | 5.22 | 8.94 | 12.20 | 13.27 | 13.68 | 10.41 | 10.18 | 12.70 | 16.85 |
Current Ratio | 10.96 | 22.76 | 12.52 | 5.22 | 8.94 | 12.20 | 13.27 | 13.68 | 10.41 | 10.18 | 12.70 | 16.85 |
Asset Turnover | 0.00 | n/a | 0.14 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -8.36 | -6.65 | -0.02 | -6.1 | -5.76 | -5.59 | -6.52 | -7.28 | -11.89 | -42.51 | n/a | n/a |
Return on Equity | -0.14 | -0.1 | -0.01 | -0.34 | -1.01 | -0.46 | -0.37 | -0.29 | -0.2 | -0.26 | -0.22 | -0.14 |
Return on Assets | -0.1 | -0.08 | n/a | -0.14 | -0.26 | -0.17 | -0.17 | -0.15 | -0.13 | -0.18 | -0.2 | -0.13 |
Return on Invested Capital | -0.1 | -0.07 | n/a | -0.16 | -0.25 | -0.16 | -0.16 | -0.15 | -0.13 | -0.2 | -0.21 | -0.14 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.02 | n/a | 0.99 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -735.12 | n/a | -0.03 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -735.12 | n/a | -0.03 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | -745.58 | n/a | -0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -744.6 | n/a | 0.13 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |